Dr Frankel talks about his experience with prostate cancer therapies that have reduced his testosterone and the effect it has had on his life.
EVALUATING THE NEW HEMP CBD PRODUCTS
I have always been, and will always be, a fan of “whole plant.” To me, “whole plant” means having as many of the cannabinoids, terpenes, flavonoids, lipids and other molecules included in a clean extraction and preserved as much as possible during decarboxylation.
“Whole plant” involves the buds as well as the sugar trim, or just the trim alone, all rich in terpenes. Leaves add little to the extract, not to mention they create a tincture with a bitter taste. The current whole plant cannabis tinctures carry the scent of raw cannabis and are rich in terpenes. If it smells like cannabis, it was probably made from cannabis. If it has no scent, it is probably produced largely from industrial hemp, or isolates or distillates.
These isolate and distillate products are pure (or nearly pure) CBD and even come in crystalline form, but are stripped of the hundreds of molecules present within the whole plant extract. The tremendous benefit that these molecules have upon one another, as well as upon our internal endocannabinoid system, are lost. The current industrial hemp or isolate/distillate molecules are weak medicines requiring a much higher dose for efficacy than that of dosed CBD derived from whole plant extracts. Additionally, we might possibly begin seeing more drug interactions with these very high doses of CBD. The resulting larger dose may very well trigger more drug interactions thru the P-450 metabolic process in the liver.
Following the passage of the “Hemp Bill” earlier this year, it became legal to sell any
cannabis/hemp product defined as having THC levels of 0.3% or less. Several of the so-called 20:1 CBD:THC strains have THC levels as low as 0.4% at harvest time. Because of that, some growers have even picked the plants 3 weeks early to reduce the THC levels down to 0.3%, therefore still qualifying as hemp. However, as the THC is reduced, along with it all of the beneficial terpenes and other molecules are reduced.
These new strains generally all test THC at 0.3% at 8 weeks of flowering. What if the CBD plants with 0.4% THC are bred for another generation or two in search of the magical 0.3% THC? (By the way, it is only magical for legal and financial reasons, as the current strains at 0.4% or 0.5% make the same medicine.)
There is legitimate concern that these growers and manufacturers will eventually get themselves into trouble. There’s a lot of grey area here. I honestly don’t believe that these prematurely harvested CBD strains are a solution.
So up until now, it has been easy for me to be in favor of whole plant and opposed to isolates, distillates or single molecule hemp CBD extractions. It made sense. However, the story is evolving and becoming more complicated, and surprisingly, I believe this may potentially be good news.
On the plus side, seeds for these new strains are available most specifically as feminized seeds, meaning that every single seed will produce a flowering female plant with THC of 0.3%. These strains appear to be good producers, as many of them test out at over 18% CBD. Being able to use low cost feminized seeds will save a lot of money and hassle with cloning.
As a result, in the not so distant future, we just might be using the word “hemp” in a more favorable view.
You Might Also Enjoy...
Dr Frankel talks about his experience with prostate cancer therapies that have reduced his testosterone and the effect it has had on his life.
With COVID, we have never been more aware of critical shortages of masks, ventilators, hospital beds, etc., all leading to rationing. In this BLOG, Dr Frankel, examines how rationing in our medical care is a much bigger problem than just face masks.
There are "acid" and "neutral" forms of every cannabinoid molecule. Early man knew the difference and would either just eat the cannabis raw, or heat it to convert to the neutral or "active" forms of the cannabinoids.
Cookie Bekkar is a cancer survivor and patient of Dr Frankel's. She has created a website to share her story, what worked well for her and as a resource help inspire/educate other patients.
Early studies in both Israel and Canada show findings consistent with CBD's effect on COVID-19's ability to take hold in the lungs or the gastrointestinal tract. If the receptors are reduced, the viral infection and pulmonary toxicity should be reduced.
CBD has recently been studied to help with Graft Versus Host Disease which can occur after an organ transplant. Dr Frankel also highlights potential dosing with whole plant cannabis and why whole plant cannabis is more beneficial to single molecule CBD.